Raising Your Streetiq

HemispherX Impresses at Urchin Cap (AMEX: HEB)

Informações:

Sinopsis

Pharma companies always seem to have a buzz in the news but when the investment community takes notice there could be a real story. Hear from Dr. William A. Carter, CEO of HemispherX Biopharma (HEB) about their latest prospects addressing stress disorders.